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than one year and 7 (15%) reported billing for 1–3 years.
Nine (20%) reported billing Third Party Payers and 5
(11%) reported providing patients an invoice to bill their
insurance carrier. Thirteen (28%) responded that they
charge a ﬂat fee and 11 (24%) documented how their
intervention saves the patients and insurance companies
money. Twenty-eight (61%) responded that their work-
load limits the amount of PCS that can be provided. Five
(11%) reported that provision of PCS is not recognized
by their state. Thirty-four (73%) were not given any
incentives for providing PCS and 30 (65%) spend over
60 minutes per day on providing PCS. Thirty-ﬁve (76%)
strongly agree that PCS enhances their relationship with
patients, 20 (43%) strongly agree that it is easy to contact
prescribers, 19 (41%) strongly agree that providing 
PCS enhances their relationship with their patients’ pre-
scribers, and 28 (61%) strongly disagree that providing
PCS interferes with the pharmacist-prescriber relation-
ship. CONCLUSION: The above response rates are
indicative of the issues that Ambulatory Care Pharmacists
at US Schools of Pharmacy deal with. Further surveys
should be taken to study the trends of reimbursement 
to ambulatory-care Pharmacists at US Schools of 
Pharmacy.
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OBJECTIVE: In response to rising medical costs in its
workers’ compensation, New York State developed an
integrated workers’ compensation/health insurance phar-
macy beneﬁt program, ONECARD Rx, to beneﬁt from
various cost containment strategies used by these plans.
Implemented in January 1998, the program allowed State
employees to use their health insurance coverage to pur-
chase drugs for work-related injuries and illnesses. The
objective of this study is to examine the program’s effect
on quality through evaluating member satisfaction and
health outcomes, as well as estimating potential cost
savings. METHODS: All 462 users identiﬁed were mailed
a survey. A sample consisting of 1514 nonusers was sur-
veyed. An assessment of the perceived importance and
desirability of various elements of ONECARD Rx was
assessed. Also, a comparison of users’ and nonuser’s sat-
isfaction with their respective prescription drug plans,
health status and time to return to work was conducted
between the two groups. Potential cost savings were 
estimated based on the different scenarios of projected 
use of the program by WC claimants in the system.
RESULTS: Results from the survey show that over 80%
of ONECARD Rx users rated their prescription drug
program excellent, very good, or good compared to 47%
eligible users (p < 0.001). A marginally signiﬁcant dif-
ference was detected between the two groups in health
status, with users reporting better health. Findings show
that the three most liked features of the beneﬁt included
requiring no co-payment, no separate forms (from non-
employment-related injuries and illnesses), and utilization
history review to identify adverse interactions with other
drugs. The analysis of potential cost savings revealed that
a 30–36% reduction in costs could be achieved assuming
that of ONECARD Rx is used by all WC claimants.
CONCLUSION: Strategies dealing with increases in WC
prescription drugs should primarily aim at improving the
quality of care delivered to workers, and doing so in a
cost-effective manner.
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